David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.63B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SPCX
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.78% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 7.91% |
| 4 | Consumer Discretionary | 7.83% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MBX
1701
MBX Biosciences
MBX
$3.29B
| $10.1M | ﹤0.01% |
182,767
-106,122
| -37% | -$3.71M |
|
1702
Griffon
GFF
$4.57B
| $10.1M | ﹤0.01% |
103,229
-152,387
| -60% | -$13.3M |
|
1703
PUT
Argan
AGX
$6.41B
| $10.1M | ﹤0.01% |
12,600
+6,400
| +103% | +$4.26M |
|
1704
Carlyle Group
CG
$17.4B
| $10.1M | ﹤0.01% |
238,883
+221,354
| +1,263% | +$10.4M |
|
1705
CALL
Whirlpool
WHR
$2.62B
| $10.1M | ﹤0.01% |
255,000
-27,800
| -10% | -$1.3M |
|
1706
Nucor
NUE
$55.8B
| $10M | ﹤0.01% |
44,983
+34,595
| +333% | +$7.83M |
|
|
AXIN
1707
Axiom Intelligence Acquisition Corp 1
AXIN
$281M
| $10M | ﹤0.01% |
968,981
+100
| +0% | +$1.03K |
|
1708
Vermilion Energy
VET
$1.89B
| $10M | ﹤0.01% |
1,070,934
-68,300
| -6% | -$812K |
|
|
EFC
1709
Ellington Financial
EFC
$1.75B
| $10M | ﹤0.01% |
735,331
+197,821
| +37% | +$2.62M |
|
1710
PUT
Wheaton Precious Metals
WPM
$73.3B
| $10M | ﹤0.01% |
+89,100
| New | +$11.6M |
|
1711
PUT
Blackrock
BLK
$182B
| $10M | ﹤0.01% |
+10,400
| New | +$10.8M |
|
1712
PUT
Ares Management
ARES
$31.6B
| $9.97M | ﹤0.01% |
89,600
+4,600
| +5% | +$552K |
|
1713
ATN International
ATNI
$476M
| $9.94M | ﹤0.01% |
375,137
+1,566
| +0.4% | +$42.6K |
|
|
JMIA
1714
Jumia Technologies
JMIA
$850M
| $9.93M | ﹤0.01% |
1,408,044
-1,606,353
| -53% | -$11.4M |
|
1715
CALL
Krystal Biotech
KRYS
$10.5B
| $9.92M | ﹤0.01% |
26,700
+17,300
| +184% | +$5.17M |
|
1716
CALL
TC Energy
TRP
$65B
| $9.92M | ﹤0.01% |
150,000
| – | – |
|
1717
Idacorp
IDA
$8B
| $9.92M | ﹤0.01% |
65,573
+32,946
| +101% | +$4.74M |
|
1718
Telus
TU
$15.4B
| $9.91M | ﹤0.01% |
937,906
-916,532
| -49% | -$11.2M |
|
|
XCBE
1719
X3 Acquisition Corp
XCBE
$281M
| $9.89M | ﹤0.01% |
990,000
+340,000
| +52% | +$3.37M |
|
1720
VeriSign
VRSN
$26.2B
| $9.88M | ﹤0.01% |
39,260
+3,695
| +10% | +$1.03M |
|
1721
Artivion
AORT
$1.29B
| $9.85M | ﹤0.01% |
438,216
+431,690
| +6,615% | +$12.1M |
|
1722
CALL
Abbott
ABT
$200B
| $9.85M | ﹤0.01% |
108,500
+5,000
| +5% | +$456K |
|
1723
Brink's
BCO
$4.55B
| $9.83M | ﹤0.01% |
104,066
+67,314
| +183% | +$7.01M |
|
|
HVII
1724
Hennessy Capital Investment Corp VII
HVII
$204M
| $9.83M | ﹤0.01% |
940,500
| – | – |
|
1725
CALL
Williams Companies
WMB
$87.8B
| $9.81M | ﹤0.01% |
+131,900
| New | +$9.71M |
|
Similar funds
David Shaw's Q2 2026 Portfolio in Review
As of Q2 2026, David Shaw held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
David Shaw deployed $7.01B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- David Shaw's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.63B increase.
- David Shaw's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- David Shaw fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- David Shaw's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- David Shaw opened 872 new positions and closed 527 in Q2 2026.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.